341 related articles for article (PubMed ID: 27650832)
21. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology.
Recht A; Edge SB; Solin LJ; Robinson DS; Estabrook A; Fine RE; Fleming GF; Formenti S; Hudis C; Kirshner JJ; Krause DA; Kuske RR; Langer AS; Sledge GW; Whelan TJ; Pfister DG;
J Clin Oncol; 2001 Mar; 19(5):1539-69. PubMed ID: 11230499
[TBL] [Abstract][Full Text] [Related]
22. Postmastectomy Radiotherapy After Neoadjuvant Chemotherapy: A Review of the Evidence.
Chapman CH; Jagsi R
Oncology (Williston Park); 2015 Sep; 29(9):657-66. PubMed ID: 26384802
[TBL] [Abstract][Full Text] [Related]
23. Management of patients with locally advanced breast cancer.
Lee MC; Newman LA
Surg Clin North Am; 2007 Apr; 87(2):379-98, ix. PubMed ID: 17498533
[TBL] [Abstract][Full Text] [Related]
24. Surgeon motivations behind the timing of breast reconstruction in patients requiring postmastectomy radiation therapy.
Lee M; Reinertsen E; McClure E; Liu S; Kruper L; Tanna N; Brian Boyd J; Granzow JW
J Plast Reconstr Aesthet Surg; 2015 Nov; 68(11):1536-42. PubMed ID: 26277336
[TBL] [Abstract][Full Text] [Related]
25. Increased utilization of postmastectomy radiotherapy in the United States from 2003 to 2011 in patients with one to three tumor positive nodes.
Yao K; Liederbach E; Lutfi W; Wang CH; Hou N; Karrison T; Huo D
J Surg Oncol; 2015 Dec; 112(8):809-14. PubMed ID: 26486998
[TBL] [Abstract][Full Text] [Related]
26. American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline for Management of Hereditary Breast Cancer.
Yip CH; Newman LA
JAMA Surg; 2021 Mar; 156(3):284-285. PubMed ID: 33439213
[No Abstract] [Full Text] [Related]
27. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
[TBL] [Abstract][Full Text] [Related]
28. National Evaluation of the New Commission on Cancer Quality Measure for Postmastectomy Radiation Treatment for Breast Cancer.
Minami CA; Bilimoria KY; Hansen NM; Strauss JB; Hayes JP; Feinglass JM; Bethke KP; Rydzewski NR; Winchester DP; Palis BE; Yang AD
Ann Surg Oncol; 2016 Aug; 23(8):2446-55. PubMed ID: 27169774
[TBL] [Abstract][Full Text] [Related]
29. The Evolving Role of Postmastectomy Radiation Therapy.
Everett AS; De Los Santos JF; Boggs DH
Surg Clin North Am; 2018 Aug; 98(4):801-817. PubMed ID: 30005775
[TBL] [Abstract][Full Text] [Related]
30. Are there patients with T1 to T2, lymph node-negative breast cancer who are "high-risk" for locoregional disease recurrence?
Mamtani A; Patil S; Stempel MM; Morrow M
Cancer; 2017 Jul; 123(14):2626-2633. PubMed ID: 28334423
[TBL] [Abstract][Full Text] [Related]
31. Impact of postmastectomy radiation therapy in T1-2 breast cancer patients with 1-3 positive axillary lymph nodes.
Yin H; Qu Y; Wang X; Ma T; Zhang H; Zhang Y; Li Y; Zhang S; Ma H; Xing E; Liu X; Xu Q
Oncotarget; 2017 Jul; 8(30):49564-49573. PubMed ID: 28484094
[TBL] [Abstract][Full Text] [Related]
32. Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
Lyman GH; Somerfield MR; Bosserman LD; Perkins CL; Weaver DL; Giuliano AE
J Clin Oncol; 2017 Feb; 35(5):561-564. PubMed ID: 27937089
[TBL] [Abstract][Full Text] [Related]
33. The role of postmastectomy radiotherapy in clinically node-positive, stage II-III breast cancer patients with pathological negative nodes after neoadjuvant chemotherapy: an analysis from the NCDB.
Liu J; Mao K; Jiang S; Jiang W; Chen K; Kim BY; Liu Q; Jacobs LK
Oncotarget; 2016 Apr; 7(17):24848-59. PubMed ID: 26709538
[TBL] [Abstract][Full Text] [Related]
34. Objection to postoperative radiation therapy in breast cancer with one to three lymph nodes involvements.
Ishikawa T; Kaise H; Yamada K; Hosonaga M; Chishima T; Narui K; Yamada A; Sugae S; Ichikawa Y; Ota M; Nozaki M; Mikami R; Tokuuye K
Breast Cancer; 2017 Jul; 24(4):496-501. PubMed ID: 28070832
[TBL] [Abstract][Full Text] [Related]
35. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
36. Non-compliance with a postmastectomy radiotherapy guideline: decision tree and cause analysis.
Razavi AR; Gill H; Ahlfeldt H; Shahsavar N
BMC Med Inform Decis Mak; 2008 Sep; 8():41. PubMed ID: 18803875
[TBL] [Abstract][Full Text] [Related]
37. NCCN Guidelines Update: Evolving Radiation Therapy Recommendations for Breast Cancer.
Salerno KE
J Natl Compr Canc Netw; 2017 May; 15(5S):682-684. PubMed ID: 28515243
[TBL] [Abstract][Full Text] [Related]
38. Postmastectomy radiotherapy: a review.
Kunkler IH; Chua BH
Curr Opin Oncol; 2021 Nov; 33(6):547-552. PubMed ID: 34494609
[TBL] [Abstract][Full Text] [Related]
39. A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer.
Truong PT; Olivotto IA; Speers CH; Wai ES; Berthelet E; Kader HA
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):797-804. PubMed ID: 14967436
[TBL] [Abstract][Full Text] [Related]
40. Breast Cancer Tumor Board: A Radiologist's Guide to Postmastectomy Radiation Therapy.
Machado LB; Brody MB; Rotenberg SE; Stachelek GC; Fernandez JG
Radiographics; 2023 Mar; 43(3):e220086. PubMed ID: 36795596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
